COMPANY
Bionovax Corp was founded in 2014. Our plant is located in Longtan of Hsinchu Science Park of Taiwan. Company goal is to produce reliable high-quality anti-coagulation drug of heparin (UFH), along with its low-molecular-weight heparin (LMWH) and their applications, which go beyond the anti-coagulation drugs to produce products that can be used in cosmetics and medical devices.
Origin
In 2008, an incident led to the deaths of hundreds of people worldwide due to fake heparin. In Taiwan, many dialysis patients also tragically died after using fake heparin API injections during their dialysis treatments.
Sustainability
Bionovax has decided to establish Taiwan’s first heparin raw material manufacturing plant. Based in Taiwan, we aim to create a new production hub focused on the heparin industry chain, integrating upstream, midstream, and downstream sectors. This includes everything from agricultural livestock production and processing of pigs to the research and development of drug extraction, ultimately connecting these processes to become a leader in the advanced pharmaceutical industry globally.
Succession
After establishing Taiwan’s first heparin API plant, we are committed to upholding GMP principles, ensuring that the entire heparin industry chain and its related derivative products consistently maintain high quality. Sustaining this commitment over the long term is our greatest challenge moving forward!
PRODUCTS
Heparin API products, supplying to companies manufacturing injectable for anti-coagulation purpose in pharmaceutical applications, e.g. kidney dialysis, critical surgeries etc.
Application of heparin products used in other biomedical and prophylactic applications.
A modern manufacturing facility is completed, complying PIC/S GMP and cGMP, to supply crucial heparin finished products globally.
Product
We manufacture and supply APIs of heparin sodium, heparin lithium and low-molecular-weight heparin. Other extended products, e.g. DPS, as well as developing the medical applications of GAG products.
We at Bionovax procure the crude supplies with traceability from collaborate partners around the world.
Bionovax passed PIC/S GMP and GDP assessment for Heparin Sodium
We received an official certificate from TFDA that Bionovax passed the PIC/S GMP and GDP assessment for Heparin Sodium. fda.gov.tw – GMP/GDP – Bionovax
Speech: Application of natural polymers in anticoagulant and other medicines – Oct.23, 2019 (Wed)
Speaker: Dr.Chuu (President of Bionovax) Topic: Application of natural polymers in anticoagulant and other medicines Date: October 23, 2019 (Wed) Location: National Chin-Yi University of Technology
BIONOVAX CORP
ADDRESS：No. 68, Longyuan 7th Road, Long Tan, Taoyuan, Taiwan
PHONE：+886-3-499-5099、886-3-275-5096
URL：http://bionovax.com/
